Regulation of Lymphocyte Function by PPARγ in Thyroid Eye Disease
Author Information
Author(s): G. M. Lehmann, T. M. Garcia-Bates, T. J. Smith, S. E. Feldon, R. P. Phipps
Primary Institution: University of Rochester Medical Center
Hypothesis
PPARγ may play divergent roles in the progression of thyroid eye disease (TED) by affecting lymphocyte and fibroblast interactions.
Conclusion
PPARγ activation could potentially be targeted for therapeutic strategies in managing thyroid eye disease-related inflammation.
Supporting Evidence
- Thyroid eye disease is characterized by inflammation and tissue remodeling in the orbit.
- PPARγ has both anti-inflammatory and pro-adipogenic effects, complicating its role in TED.
- Interactions between lymphocytes and fibroblasts are crucial in the pathogenesis of TED.
Takeaway
This study looks at how a protein called PPARγ affects immune cells in a disease that causes eye problems. It suggests that changing how PPARγ works might help treat this disease.
Methodology
The review discusses the role of PPARγ in thyroid eye disease, focusing on the interactions between lymphocytes and fibroblasts.
Limitations
The review is based on existing literature and does not present new experimental data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website